Used together, ATO and ATRA cooperatively ablate Pin1, thereby blocking numerous cancer-driving pathways and inhibiting TICs and tumor growth of TNBC, similar to Pin1 KO in human cells and in orthotopic tumor models, including PDOX. The gene discussed is PIN1; the disease is neoplasm.